Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (351-360 of 388) with videos related to

Pageof 39
Sort By:
The Lancet. Global Health|March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyRebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.
Vaccines|April 27, 2024
The Full Value of Vaccine Assessments Concept-Current Opportunities and RecommendationsRichard G White, Nicolas A Menzies, Allison Portnoy, et al.
Vaccines|September 28, 2024
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income CountriesMelissa Ko, Collrane Frivold, Mercy Mvundura, et al.
BMC Public Health|January 7, 2023
The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15-18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in ChinaYifan Li, Chuanyu Qin, Shengyue Qiu, et al.
Plos Medicine|November 4, 2025
Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: A modeling studyBoshen Jiao, Ryoko Sato, Joshua Mak, et al.
The Lancet. Microbe|October 12, 2023
Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort studyMei Li, Wei Wang, Junbo Chen, et al.
BMJ Open|February 22, 2023
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT)Emily Herrett, Keith Tomlin, Liang-Yu Lin, et al.
Vaccine|November 28, 2021
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogensMateusz Hasso-Agopsowicz, Benjamin A Lopman, Claudio F Lanata, et al.
BMC Infectious Diseases|December 1, 2019
Mathematical modelling for antibiotic resistance control policy: do we know enough?Gwenan M Knight, Nicholas G Davies, Caroline Colijn, et al.
The Lancet. Child & Adolescent Health|April 24, 2021
Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort studyErzsébet Horváth-Puhó, Merel N van Kassel, Bronner P Gonçalves, et al.
Pageof 39

Showing results (351-360 of 388) with videos related to

Sort By:
Pageof 39
The Lancet. Global Health|March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyRebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.
Vaccines|April 27, 2024
The Full Value of Vaccine Assessments Concept-Current Opportunities and RecommendationsRichard G White, Nicolas A Menzies, Allison Portnoy, et al.
Vaccines|September 28, 2024
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income CountriesMelissa Ko, Collrane Frivold, Mercy Mvundura, et al.
BMC Public Health|January 7, 2023
The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15-18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in ChinaYifan Li, Chuanyu Qin, Shengyue Qiu, et al.
Plos Medicine|November 4, 2025
Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: A modeling studyBoshen Jiao, Ryoko Sato, Joshua Mak, et al.
The Lancet. Microbe|October 12, 2023
Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort studyMei Li, Wei Wang, Junbo Chen, et al.
BMJ Open|February 22, 2023
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT)Emily Herrett, Keith Tomlin, Liang-Yu Lin, et al.
Vaccine|November 28, 2021
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogensMateusz Hasso-Agopsowicz, Benjamin A Lopman, Claudio F Lanata, et al.
BMC Infectious Diseases|December 1, 2019
Mathematical modelling for antibiotic resistance control policy: do we know enough?Gwenan M Knight, Nicholas G Davies, Caroline Colijn, et al.
The Lancet. Child & Adolescent Health|April 24, 2021
Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort studyErzsébet Horváth-Puhó, Merel N van Kassel, Bronner P Gonçalves, et al.
Pageof 39